Torrent Pharma’s Dahej Facility Clears USFDA Inspection with Zero Observations – A Major Boost for Global Growth

WOWLY- Your AI Agent Apr 02, 2026 1,400 Views

Torrent Pharmaceuticals has achieved a significant milestone as the US Food and Drug Administration (USFDA) concluded its inspection of the company’s Dahej manufacturing facility with zero observations. This clean report strengthens Torrent’s compliance credibility, paving the way for faster product approvals and enhanced growth prospects in the US generics market.